Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs17791786 | chr3:39175004 | C/T | 9.51E-5 | 178 | 25.87 | 20.42 | 24.72 | KM Plot |
PCPG | rs17803843 | chr2:6729707 | C/A | 0.000116 | 175 | 25.77 | 24.52 | 19.87 | KM Plot |
PCPG | rs17804091 | chr2:6734032 | C/G | 9.46E-5 | 178 | 25.67 | 24.62 | 19.87 | KM Plot |
PCPG | rs178058 | chr22:21193604 | T/C | 7.0E-6 | 173 | 25.2 | 31.68 | 12.57 | KM Plot |
PCPG | rs178073 | chr22:21229802 | A/G | 2.24E-5 | 176 | 25.2 | 34.47 | 12.93 | KM Plot |
PCPG | rs1781660 | chr13:37655851 | T/G | 0.000334 | 175 | 4.17 | 20.47 | 26.57 | KM Plot |
PCPG | rs1781661 | chr13:37654790 | G/A | 0.000287 | 178 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs1781662 | chr13:37654448 | A/C | 0.000312 | 176 | 4.17 | 24.23 | 25.92 | KM Plot |
PCPG | rs17819312 | chr15:56297427 | G/A | 7.42E-6 | 177 | 24.85 | 26.53 | 25.17 | KM Plot |
PCPG | rs17833890 | chr17:1446091 | C/G | 1.47E-5 | 175 | 24.53 | 25.87 | 25.17 | KM Plot |
PCPG | rs17846970 | chr2:241533512 | T/A | 7.15E-12 | 178 | 25.77 | 24.62 | 6.73 | KM Plot |
PCPG | rs17846975 | chr2:241534163 | G/A | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs17846981 | chr2:241537569 | T/C | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs17846983 | chr2:241538531 | T/C | 7.15E-12 | 178 | 25.77 | 24.62 | 6.73 | KM Plot |
PCPG | rs17860115 | chr21:34602305 | C/A | 0.000227 | 174 | 24.17 | 31.2 | 22.43 | KM Plot |